华熙生物(688363.SH)：前三季度净利润2.52亿元，同比下降30.29%

Core Viewpoint - Huaxi Biological (688363.SH) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - Total operating revenue for the first three quarters reached 3.163 billion yuan, a year-on-year decrease of 18.36% [1] - Net profit attributable to shareholders was 252 million yuan, down 30.29% year-on-year [1] - Basic earnings per share stood at 0.52 yuan [1]